N/A
Completed N=142
Evaluation of Microcirculatory Function and Mitochondrial Respiration After Cardiovascular Surgery
Source: ClinicalTrials.gov NCT05330676 ↗Enrolled (actual)
142
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: Perfused Vessel Denisty (PVD) — 22.8; 23.8; 20.2; 22.5 mm/mm^2
Summary
This study will examine the differences in microcirculatory function and mitochondrial respiration in patients with shock after cardiovascular surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Perfused Vessel Denisty (PVD) |
22.8; 23.8; 20.2; 22.5; 21.1; 22.8 | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients (>18 years old)
- Receiving elective coronary artery bypass graft (CABG)
- Receiving valvular surgery requiring cardiopulmonary bypass
Exclusion Criteria
- Unable to tolerate sublingual microcirculatory flow imaging (e.g., non-intubated patients dependent upon oxygen by facemask, poor mouth opening)
- receiving an emergent procedure
- have an actively treated malignancy
- mitochondrial disorder
- receiving surgery requiring deep hypothermic circulatory arrest.
Data sourced from ClinicalTrials.gov (NCT05330676). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.